AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

FIREBRICK PHARMA LTD

0.070

-0.002-2.78%

Volume:2.38K

Turnover:167.00

Market Cap:15.72M

PE:-7.78

High:0.070

Open:0.070

Low:0.070

Close:0.072

Loading ...

Overview Company News Filings

Firebrick Pharma - Nasodine Covid-19 Patent Allowed in Mexico

THOMSON REUTERS

BRIEF-Firebrick Pharma Signs Agreement To Market Nasodine To Healthcare Professionals In Singapore

Firebrick Pharma Ltd - Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore

THOMSON REUTERS

Firebrick Pharma Raises Capital via Share Purchase Plan; Shares Up 7%

MT Newswires Live

Firebrick Pharma Ltd-Firebrick Investor Update Webinar Recording

THOMSON REUTERS

Australian Shares Flat as CPI Slows in August; Sigma Healthcare Hits New 52-Week High After H1 Results

MT Newswires Live

Firebrick Pharma Eyes Global Expansion for Nasodine Nasal Spray; Shares Up 8%

MT Newswires Live

Firebrick Pharma Opens Share Purchase Plan; Shares Fall 4%

MT Newswires Live

Firebrick Pharma Ltd-Share Purchase Plan Open

THOMSON REUTERS

BRIEF-Firebrick Pharma Announces Share Purchase Plan

BUZZ-Australia's Firebrick Pharma tumbles on discounted share purchase plan

ASX Small-Cap Stocks to Watch

MT Newswires Live

ASX Small-Cap Stocks to Watch

MT Newswires Live

Firebrick Pharma Ltd - Share Purchase Plan at an Issue Price of a$0.055 per Share

THOMSON REUTERS

Firebrick Pharma Ltd - Intends to Raise up to a$2 Mln Pursuant to Spp

THOMSON REUTERS

ASX Small-Cap Stocks to Watch

MT Newswires Live

ASX Small-Cap Stocks to Watch

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FRE.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FRE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","market":"AU","secType":"STK","nameCN":"FIREBRICK PHARMA LTD","latestPrice":0.07,"timestamp":1747872127324,"preClose":0.072,"halted":0,"volume":2380,"delay":0,"nameEN":"FIREBRICK PHARMA LTD","floatShares":104130397,"shares":224576455,"eps":-0.008993,"marketStatus":"Trading","change":-0.002,"latestTime":"05-22 10:06:31 AEST","open":0.07,"high":0.07,"low":0.07,"amount":167,"amplitude":0,"askPrice":0.077,"askSize":14828,"bidPrice":0.071,"bidSize":37061,"shortable":3,"etf":0,"ttmEps":-0.008993,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1747893600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.072,"openAndCloseTimeList":[[1747872000000,1747893600000]],"volumeRatio":4.044997,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","floatShares":104130397,"roa":"-52.89%","roe":"-111.71%","lyrEps":-0.006568,"volumeRatio":4.044997,"shares":224576455,"dividePrice":0,"high":0.07,"amplitude":0,"preClose":0.072,"low":0.07,"week52Low":0.045,"pbRate":"10.50","psRate":"13.90","week52High":0.1,"institutionHeld":0,"latestPrice":0.07,"committee":0.428472,"eps":-0.008993,"divideRate":0,"volume":2380,"delay":0,"ttmEps":-0.008993,"open":0.07,"prevYearClose":0.062,"prevWeekClose":0.071,"prevMonthClose":0.068,"prevQuarterClose":0.091,"fiveDayClose":0.071,"twentyDayClose":0.072,"sixtyDayClose":0.087},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FRE.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2480096465","title":"Firebrick Pharma - Nasodine Covid-19 Patent Allowed in Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2480096465","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480096465?lang=en_us&edition=fundamental","pubTime":"2024-11-01 06:38","pubTimestamp":1730414290,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nFWN3M71OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2479718491","title":"BRIEF-Firebrick Pharma Signs Agreement To Market Nasodine To Healthcare Professionals In Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2479718491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479718491?lang=en_us&edition=fundamental","pubTime":"2024-10-31 09:31","pubTimestamp":1730338304,"startTime":"0","endTime":"0","summary":"Oct 31 (Reuters) - Firebrick Pharma Ltd   :   * AGREEMENT SIGNED TO MARKET NASODINE TO HEALTHCARE PROFESSIONALS IN SINGAPORESource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2479761035","title":"Firebrick Pharma Ltd - Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2479761035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479761035?lang=en_us&edition=fundamental","pubTime":"2024-10-31 05:41","pubTimestamp":1730324515,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nFWN3M61XQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2474756780","title":"Firebrick Pharma Raises Capital via Share Purchase Plan; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474756780","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474756780?lang=en_us&edition=fundamental","pubTime":"2024-10-10 11:48","pubTimestamp":1728532110,"startTime":"0","endTime":"0","summary":"Firebrick Pharma  raised around AU$800,000 via a share purchase plan at AU$0.055 apiece, according to a Thursday filing with the Australian bourse.The pharmaceutical firm raised AU$635,600 following the completion of its share purchase plan comprising the issue of roughly 11.6 million fully paid ordinary shares.Further, the company received commitments or applications for an additional AU$158,700 worth of shares. Settlement is expected to occur by Oct. 15.Proceeds will be used to fund Firebrick Pharma's marketing initiatives for Nasodine nasal spray in Singapore and the US, the filing stated.Firebrick Pharma's shares were up more than 7% in recent trade.Price : $0.06, Change: $+0.0040, Percent Change: +7.27%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4125","AUD","FRE.AU","BK7096"],"gpt_icon":0},{"id":"2472494663","title":"Firebrick Pharma Ltd-Firebrick Investor Update Webinar Recording","url":"https://stock-news.laohu8.com/highlight/detail?id=2472494663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472494663?lang=en_us&edition=fundamental","pubTime":"2024-10-01 17:03","pubTimestamp":1727773435,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241001:nTUE5KTGHY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2470856652","title":"Australian Shares Flat as CPI Slows in August; Sigma Healthcare Hits New 52-Week High After H1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2470856652","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470856652?lang=en_us&edition=fundamental","pubTime":"2024-09-25 15:00","pubTimestamp":1727247621,"startTime":"0","endTime":"0","summary":"Australian shares were flat with a negative bias on Wednesday following a report showing that the domestic consumer price index slowed to its lowest point in three years.The S&P/ASX 200 index was litt","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","XAO.AU","BK7103","ERA.AU","BK4137","FRE.AU","HCSG","XKO.AU","BK7096","BK7083","SIG.AU"],"gpt_icon":0},{"id":"2470408064","title":"Firebrick Pharma Eyes Global Expansion for Nasodine Nasal Spray; Shares Up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470408064","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470408064?lang=en_us&edition=fundamental","pubTime":"2024-09-25 11:41","pubTimestamp":1727235693,"startTime":"0","endTime":"0","summary":"Firebrick Pharma  intends to get its Nasodine nasal spray approved in all markets over the long term to receive royalties and license fees through its partners, according to a Wednesday filing with the Australian bourse.In its investor update, Firebrick Pharma said it expects a decision on its application for Nasodine to be marketed as a nasal antiseptic in Europe in 2025. Once approved, the company plans to lodge its application in New Zealand and South Africa.Nasodine is being marketed as a nasal cleanser in the US, where the company plans to pursue pharmacy distribution.In the Philippines, the product is expected to be launched as a nasal antiseptic in 2025.The pharmaceutical company's shares were up nearly 8% in recent Wednesday trade.Price : $0.06, Change: $+0.004, Percent Change: +7.69%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AUD","FRE.AU","BK7096","BK4125"],"gpt_icon":0},{"id":"2468386405","title":"Firebrick Pharma Opens Share Purchase Plan; Shares Fall 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468386405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468386405?lang=en_us&edition=fundamental","pubTime":"2024-09-17 13:45","pubTimestamp":1726551927,"startTime":"0","endTime":"0","summary":"Firebrick Pharma  opened a share purchase plan on Tuesday to raise up to AU$2 million, according to a same-day filing with the Australian bourse.As previously disclosed, shareholders on record as of Sept. 11 will be able to buy up to AU$30,000 worth of ordinary shares at AU$0.055 apiece.Proceeds from the capital raise will be used for general working capital and to expand marketing activities for the Nasodine nasal spray in the US and Singapore, the pharmaceutical firm said in the filing.The share purchase plan is set to close on Oct. 7, with the issue and quotation of shares on the Australian bourse scheduled for Oct. 10.Shares of Firebrick Pharma fell nearly 4% in recent Tuesday trade.Price : $0.05, Change: $-0.0020, Percent Change: -3.57%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","XKO.AU","AUD","FRE.AU","BK4125","BK7096","XJO.AU"],"gpt_icon":0},{"id":"2468780310","title":"Firebrick Pharma Ltd-Share Purchase Plan Open","url":"https://stock-news.laohu8.com/highlight/detail?id=2468780310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468780310?lang=en_us&edition=fundamental","pubTime":"2024-09-17 09:16","pubTimestamp":1726535812,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240917:nTUE5RQSZH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2466291885","title":"BRIEF-Firebrick Pharma Announces Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2466291885","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466291885?lang=en_us&edition=fundamental","pubTime":"2024-09-12 09:28","pubTimestamp":1726104532,"startTime":"0","endTime":"0","summary":"Sept 12 (Reuters) - Firebrick Pharma Ltd   :   * SHARE PURCHASE PLAN AT AN ISSUE PRICE OF A$0.055 PER SHARE   * INTENDS TO RAISE UP TO A$2 MILLION PURSUANT TO SPPFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2466229667","title":"BUZZ-Australia's Firebrick Pharma tumbles on discounted share purchase plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2466229667","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466229667?lang=en_us&edition=fundamental","pubTime":"2024-09-12 09:02","pubTimestamp":1726102922,"startTime":"0","endTime":"0","summary":"** Shares of Firebrick Pharma    fall as much as 9.2% to A$0.059, posting their biggest intraday percentage decline since May 28   ** Stock hits its lowest level since Aug 21   ** Pharmaceutical co says it will raise up to A$2 mln   via share purchase plan at A$0.055 per share   ** Issue price represents a 15.4% discount on co's last close   ** About 986,000 shares change hands, compared with the 30-day average volume of around 102,000   ** Stock up 18% YTD, including session's move ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XKO.AU","BK7096","XJO.AU","FRE.AU","XAO.AU"],"gpt_icon":0},{"id":"2466126704","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2466126704","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466126704?lang=en_us&edition=fundamental","pubTime":"2024-09-12 07:46","pubTimestamp":1726098401,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Alto Metals (ASX:AME)Alto Metals started a reverse circulation drilling program at it","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRE.AU","BK7129","AME.AU","BM8.AU","EQN.AU","XJO.AU","XAO.AU","BRX.AU","CHW.AU","BK7096","BK7104","XKO.AU","BK7095","HRZ.AU"],"gpt_icon":0},{"id":"2466075267","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2466075267","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466075267?lang=en_us&edition=fundamental","pubTime":"2024-09-12 07:46","pubTimestamp":1726098401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["MTX","BK4211","BK7104","FRE.AU","XAO.AU","AME","EQN.AU","BK7095","BK4588","BK7507","BK7504","AME.AU","BM8.AU","XKO.AU","BK4168","WRN","BK4585","BK4231","PLS.AU","XJO.AU","HRZ.AU","CHW","BK7129","ISBC","BK4096","CHW.AU","BK4109","BK4080","BRX","BK7096","BRX.AU"],"gpt_icon":0},{"id":"2466526926","title":"Firebrick Pharma Ltd -  Share Purchase Plan at an Issue Price of a$0.055 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2466526926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466526926?lang=en_us&edition=fundamental","pubTime":"2024-09-12 06:22","pubTimestamp":1726093338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240911:nFWN3KT0YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2466263269","title":"Firebrick Pharma Ltd -  Intends to Raise up to a$2 Mln Pursuant to Spp","url":"https://stock-news.laohu8.com/highlight/detail?id=2466263269","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466263269?lang=en_us&edition=fundamental","pubTime":"2024-09-12 06:22","pubTimestamp":1726093338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240911:nFWN3KT0YD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2466546903","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2466546903","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466546903?lang=en_us&edition=fundamental","pubTime":"2024-09-09 07:41","pubTimestamp":1725838890,"startTime":"0","endTime":"0","summary":"Investors are likely to be monitoring the following small-cap stocks listed on the Australian Securities Exchange.Synlait Milk (ASX:SM1, NZE:SML)Synlait Milk completed the strategic review of its Nort","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7141","BK7016","BK7505","SM1.AU","SRI.AU","FRE.AU","BK7142","BK7095","GPR.AU","KCC.AU","BK7096","BK7104","ADA.AU","BK7509","DEV.AU","BK7083","BRU.AU"],"gpt_icon":0},{"id":"2466188359","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2466188359","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466188359?lang=en_us&edition=fundamental","pubTime":"2024-09-09 07:41","pubTimestamp":1725838890,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["AG","DEV.AU","BK7095","ADA.AU","BK4124","BK7505","US12M.BOND","BK7083","BK7046","IE0031619046.USD","US912797GL51.BOND","US10Y.BOND","BK7509","BK4210","BK7511","XJO.AU","FRE.AU","US6M.BOND","US912797HE00.BOND","BK4211","BK7016","ISBC","GPR.AU","US2Y.BOND","US30Y.BOND","XAO.AU","BK7142","US7Y.BOND","BK7096","IE00B66KJ199.SGD","WRN","KCC.AU","BK7104","US912797GW17.BOND","US3Y.BOND","MQG.AU","SM1.AU","BK4168","XKO.AU","BK7141","IE00B7SZL793.SGD","BRU.AU","US5Y.BOND","SRI","SRI.AU","IE00B19Z4B17.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":37,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FRE.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FRE.AU\",market:\"AU\",,,undefined,":[]}}